A detailed history of E Fund Management Co., Ltd. transactions in Amgen Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 9,634 shares of AMGN stock, worth $2.54 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
9,634
Previous 9,739 1.08%
Holding current value
$2.54 Million
Previous $3.04 Million 2.04%
% of portfolio
0.16%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $32,484 - $35,424
-105 Reduced 1.08%
9,634 $3.1 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $579,889 - $704,717
2,207 Added 29.3%
9,739 $3.04 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $31,995 - $38,622
-119 Reduced 1.56%
7,532 $2.14 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $85,403 - $96,345
-334 Reduced 4.18%
7,651 $2.2 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $129,659 - $160,975
593 Added 8.02%
7,985 $2.15 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $101,992 - $120,604
-476 Reduced 6.05%
7,392 $1.64 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $29,578 - $36,051
-131 Reduced 1.64%
7,868 $1.9 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $203,149 - $258,125
-887 Reduced 9.98%
7,999 $2.1 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $109,087 - $123,030
486 Added 5.79%
8,886 $2 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $81,209 - $90,372
352 Added 4.37%
8,400 $2.04 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $18,199 - $20,133
83 Added 1.04%
8,048 $1.95 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $3,778 - $4,324
19 Added 0.24%
7,965 $1.79 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $17,193 - $20,144
81 Added 1.03%
7,946 $1.69 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $1.75 Million - $2.03 Million
7,865 New
7,865 $1.96 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.